Skip to main content
Premium Trial:

Request an Annual Quote

Rafael Fonseca, Joseph M.K. Irudayaraj, Edward Maggio, Andrew Parkinson, Sangeeta Bhatia, Douglas Hixson

Premium

Rafael Fonseca has been named to the Mayo Clinic of Scottsdale, Ariz., and the Translational Genomics Institute of Phoenix to to lead a collaborative research project investigating biology, genetics, and targeted treatment of multiple myeloma, the institutes announced in May. Fonseca holds an MD from Universidad Anahuac of Mexico.


Joseph M.K. Irudayaraj, an associate professor of agricultural engineering at the Pennsylvania State University, has taken a leave of absence to conduct collaborative research on the interaction of biomolecules with inorganic surfaces for its integration with electronics for biosensor development, which has applications for food safety and homeland security, at the University of Wisconsin.


Edward Maggio, Andrew Parkinson, Sangeeta Bhatia, and Douglas Hixson join the advisory board of MultiCell Technologies of Warwick, RI.

Parkinson is the founder, chairman and chief executive officer of XenoTech. He holds a bachelor’s of science in medicinal biochemistry from the University of Surrey, England, and a PhD in biological chemistry from the University of Guelph in Ontario, Canada. He is also associate director of the Center for Environmental and Occupational Health and professor of pharmacology and toxicology at the University of Kansas Medical Center. Bhatia, an associate professor in the department of bioengineering and an associate adjunct professor in gastroenterology in the department of medicine at the University of California, San Diego, holds an MD from Harvard Medical School, and a PhD in biomedical engineering from the Massachusetts Institute of Technology. Maggio is CEO and founder of Cengent Therapeutics and the former president and CEO of ImmunoPharmaceutics. He holds a PhD from the University of Michigan. Hixson is vice president and co-founder of Prothera Biologics, a professor at Brown University, and the Director of the COBRE Center for Cancer Research at Rhode Island Hospital. He is also a research professor of medicine and pathology at Brown University. Hixon holds a BS in mathematics.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.